Synthesis and Biological Evaluation of New Geiparvarin Derivatives

Abstract

New geiparvarin derivatives modified at the unsaturated alkenyloxy bridge, where a hydrogen atom replaces the 3'-methyl group, were synthesized and evaluated against a panel of human tumor cell lines in vitro. These compounds demonstrated an increase in growth inhibitory activity relative to the parent compound, geiparvarin. The activity increased even further in the series of demethylated compounds, with the introduction of a methyl group at the 1'-position of the alkenyloxy chain. In contrast, a remarkable decrease in activity was observed with the introduction of a methyl group at the 2'-position. Interestingly, the new derivatives fully inhibited the growth of drug-resistant cell lines, suggesting that they are not subject to pump-mediated drug efflux. On the basis of their cytotoxic profiles, the most active compounds (R)-4 and (R)-5 were selected for further biological evaluation in comparison with the lead compound. The new derivatives strongly induce apoptosis in a promyelocytic leukemia cell line (HL-60) mediated by depolarization of mitochondrial transmembrane potential and mitochondrial production of reactive oxygen species (ROS).

Fraxetin Suppresses Proliferation of Non-Small-Cell Lung Cancer Cells via Preventing Activation of Signal Transducer and Activator of Transcription 3

“…Natural products, esculetin and osthole, are the two well-studied coumarin-based anticancer agents that exhibit potent in vitro cytotoxic activity against the growth of several human tumor cell lines (gastric carcinoma, colon carcinoma, and breast cancer cell line) and in vivo anti-tumor activities in xenograft models (Lee et al 2013;Wang et al 2017;Dai et al 2018;Xu et al 2018). Besides, several natural and synthetic coumarin-based drugs, including Warfarin (anti-metastasis agent) and Geiparvarin (anti-proliferation agent), have been screened and found exhibit specific anticancer effects, suggesting that these cytotoxic coumarin-based compounds represent a desirable lead for novel anticancer drug discovery with minimized toxicity to normal tissues (Chimichi et al 2009;Kirane et al 2015).…”

7‐(2‐Oxoalkoxy)coumarins: Synthesis and Anti‐Inflammatory Activity of a Series of Substituted Coumarins

“…Some applications for other 7‐(2‐oxoalkoxy)coumarins have been developed such as the use of cyclic and acyclic coumaryloxy‐ketones as fluorogenic substrates in an assay for monooxygenase enzyme activity . Also, compounds of this structure other than 7‐acetonyloxycoumarins are used as intermediates to furocoumarins and coumarin‐based structures, geiparvarins .…”

The hydrolase LpqI primes mycobacterial peptidoglycan recycling

“…Instead of the 2- or 3- step protocols published for the synthesis of 4MU- d -lactate previously, we used a simplified one step method 55,56 . In total, 1.5 g of (s)-(-)-bromopropionic acid was added to 1 g of 4-methylumbelliferone stirring in 40 mL anhydrous dimethylformamide and 0.75 g Cs 2 CO 3 .…”